Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Mammary Paget disease

Meissner K, Riviere A, Haupt G, Toning T. Study of neu-protein expression in mammary Paget disease with and without underlying breast carcinoma and in extramammary Paget disease. Am J Pathol. 1990 137 1305-1309. [Pg.255]

Anderson JM, Ariga R, Govil H, et al. Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol. 2003 11 120-124. [Pg.813]

Edorh, A., Parache, R. M., Migeon, C., N Sossani, B., and Rihn, B. 1995. Expression of the c-erbB-2 oncoprotein in mammary Paget s disease. Immunohistochemical study by using 3 antibodies. Pathol. Biol (Paris) 43 584—589. [Pg.314]

Tumors that are characteristically strongly and diffusely positive include those of the salivary glands, lung, breast, ovary, endometrium, bladder, and thymus, as well as mesotheliomas, neuroendocrine tumors, pancreaticobili-ary adenocarcinomas, and the fibrolamellar variant of hepatocellular carcinoma. 33 CK7 is also typically expressed in tumor cells of mammary and extramammary Paget disease. 34... [Pg.214]

Paget disease occurs in mammary and extramammary (EM) forms. Paget disease of the breast is almost always indicative of an underlying breast carcinoma, whereas EM Paget disease may be an indicator of metastatic carcinoma. [Pg.241]

Kondo Y, Kashima K, Daa T, et al. The ectopic expression of gastric mucin in extramammary and mammary Paget s disease. Am J Surg Pathol. 2002 26 617-623. [Pg.537]

Yim JH, Wick MR, Philpott GW, et al. Underlying pathology in mammary Paget s disease. Ann Surg Oncol. 1997 4 287-292. [Pg.813]

Yousef AA, Boccara O, Moyal-Barracco M, Zimmermarm U, Saiag P. Incomplete efficacy of 5-aminolevuIinic acid (5ALA) Photodynamic therapy in the treatment of widespread exlra-Mammary Paget s disease. Photoderm Photoim Photomed 2012 28(l) 53-5. [Pg.230]

Ramachandra S, Gillette CE, Millis RR. A comparative immu-nohistochemical study of mammary and extramammary Paget s disease and superficial spreading melanoma, with particular emphasis on melanocytic markers. Virchows Arch. 1996 429 371-376. [Pg.492]

Hitchcock A, Topham S, Bell J, et al. Routine diagnosis of mammary and extramammary Paget s disease a modern approach. Am J Surg Pathol. 1992 16 58-61. [Pg.492]

Wolber RA, Dupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget s disease. Am J Clin Pathol. 1991 96 243-247. [Pg.499]

Smith KJ, Tuur S, Corvette D, et al. Cytokeratin 7 staining in mammary and extramammary Paget s disease. Mod Pathol. 1997 10 1069-1074. [Pg.536]

Glasgow BJ, Wen DR, Al-Jitawi S, et al. Antibody to S-100 protein aids the separation of pagetoid melanoma from mammary and extramammary Paget s disease. J Cutan Pathol. 1987 14 223-226. [Pg.747]

Gillett CE, Bobrow LG, Millis RR. SI 00 protein in human mammary tissue—Immunoreactivity in breast carcinoma, including Paget s disease of the nipple, and value as a marker of myoepithelial cells./ Pathol. 1990 160 19-24. [Pg.813]


See other pages where Mammary Paget disease is mentioned: [Pg.242]    [Pg.786]    [Pg.242]    [Pg.786]    [Pg.297]    [Pg.489]    [Pg.113]   
See also in sourсe #XX -- [ Pg.785 ]




SEARCH



Mammary

Paget

Paget disease

© 2024 chempedia.info